Nabeel Ahmed

Nabeel Ahmed (finance chief) discloses dealings in Outset Medical, Inc. to SEC (Form 4). Over a trading history stretching from 16 July 2021 to 15 May 2025, the count stands at 38 filings.

In open-market terms, that means 1 purchase worth €19k on one side and 27 sales worth €477k on the other. Netting one side against the other leaves €458k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 7 share grants and 2 option exercises. 2025 to date brings no purchases and 4 sales.

The record was last updated on 16 May 2025 with an open-market sale (€9,293) in Outset Medical, Inc. The clock since the last published purchase (11 August 2021) now reads 1,894 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.